- PDSB Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-8 Filing
PDS Biotechnology (PDSB) S-8Registration of securities for employees
Filed: 1 Apr 22, 8:01am
Signature | Title | Date | ||
/s/ Frank Bedu-Addo | President, Chief Executive Officer and Director | April 1, 2022 | ||
Frank Bedu-Addo, Ph.D. | (Principal Executive Officer) | |||
/s/ Matthew Hill | Chief Financial Officer | April 1, 2022 | ||
Matthew Hill | (Principal Financial and Accounting Officer) | |||
/s/ Stephen Glover | Director | April 1, 2022 | ||
Stephen Glover | ||||
/s/ Kamil Ali-Jackson | Director | April 1, 2022 | ||
Kamil Ali-Jackson | ||||
/s/ Otis W. Brawley | Director | April 1, 2022 | ||
Otis W. Brawley | ||||
/s/ Gregory Freitag | Director | April 1, 2022 | ||
Gregory Freitag | ||||
/s/ Ilian Iliev | Director | April 1, 2022 | ||
Ilian Iliev | ||||
/s/ Sir Richard Sykes | Director | April 1, 2022 | ||
Sir Richard Sykes |